(Bloomberg) -- Eli Lilly & Co. is tapping former US vaccine chief Peter Marks to lead research into potential new medicines for infectious diseases. Marks, who formerly oversaw approval of new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback